PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60

ABSTRACT:

SUBMITTER: Parovichnikova E 

PROVIDER: S-EPMC10430313 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature